FDA Approves Wearable Cardioverter Defibrillator
The patch-based cardioverter defibrillator is approved for use in patients with a temporary elevated risk of sudden cardiac arrest.
The patch-based cardioverter defibrillator is approved for use in patients with a temporary elevated risk of sudden cardiac arrest.
Viz.ai will offer Us2.ai’s echocardiogram viewing and measurement tools with the Viz Platform to support those with suspected heart disease.
A new extravascular implantable cardioverter-defibrillator met safety and effectiveness goals for participants in a premarket clinical study.
The patch-based cardioverter defibrillator is approved for use in patients with a temporary elevated risk of sudden cardiac arrest.
Spacelabs Healthcare demonstrated new diagnostic cardiology products at the American College of Cardiology’s annual event.
Read MoreKestra Medical Technologies’ ASSURE WCD system is effective at reducing false-positive shock alarms, according to clinical evaluation results.
Read MorePhysicians accessing GE Healthcare’s cardiac management system that integrates into the EMR, can interpret data in MUSE ECGs from patients.
Read MoreRetia Medical has received a declaration of compatibility from Philips for its Argos cardiac output monitor to interface with Philips’ IntelliBridge system on the IntelliVue patient monitoring systems.
Read MoreThese ablation catheters were approved to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).
Read MoreRoyal Philips has unveiled a full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.
Read MoreAbbott has received FDA clearance for a new cardiac mapping platform that is designed to help physicians better treat abnormal heart rhythm.